News Briefs

April 2010
American Journal of Health-System Pharmacy;4/15/2010, Vol. 67 Issue 8, p597
Academic Journal
The article offers news briefs on the pharmaceutical industry. U.S. Food and Drug Administration (FDA) and Takeda Pharmaceuticals North America Inc. have announced that dexlansoprazole will now be available under brand name of Dexilant instead of Kapidex. A new drug delivery system for Somatropin injectons from Novo Nordisk, has been approved by FDA. Abbott Laboratories has acquired Solvay Pharmaceuticals.


Related Articles

  • Approvals and Filings.  // Applied Clinical Trials;Sep2005, Vol. 14 Issue 9, p20 

    Reports on drug approvals and filings with the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), as of September 2005. Takeda Pharmaceuticals North America Inc.'s receipt of FDA approval for its Rozerem 8-mg prescription sleep medication; Receipt by the EMA of a...

  • A Presence In Mexico Is Established By Takeda.  // Chain Drug Review;11/23/2009, Vol. 31 Issue 20, p43 

    The article offers news briefs in the pharmaceutical industry. Takeda Pharmaceuticals North America Inc. has launched Takeda Pharmaceuticals Mexico SA de CV in Mexico City. The Food and Drug Administration has revealed the Safe Use Initiative, a campaign that aims to reduce the likelihood of...

  • PHARMA CAPSULES.  // Pharmaceutical Technology;Jun2012, Vol. 36 Issue 6, p72 

    The article offers information related to pharmaceutical industry including the appointment of Pharma Tech Industries as the Best Overall Supplier, the new drug application for Gilead Science's Viread oral powder approved by the U.D. Food and Drug Administration (FDA), and the contract...

  • FDA APPROVES ABBOTT STARCLOSE VASCULAR CLOSURE SYSTEM.  // Worldwide Videotex Update;Feb2006, Vol. 25 Issue 2, p9 

    The article reports that Abbott has received the approval from the U.S. Food & Drug Administration to market its StarClose Vascular Closure System, a vessel closure device designed to enable faster recovery among patients who have undergone catheterization. One feature of the device is its tiny...

  • New Labeling For Takeda's Edarbi Given Green Light.  // Chain Drug Review;5/23/2011, Vol. 33 Issue 9, p75 

    The article reports on the approval by the Food and Drug Administration to Takeda Pharmaceuticals North America Inc.'s drug Edarbi in the U.S.

  • Alza Deal Braces Against Abbott's Storm. Cohen, Judy Radler // Mergers & Acquisitions Report;11/01/99, Vol. 12 Issue 43, p1 

    Reports on the proposed acquisition of Alza Corp., a designer of drug delivery systems by Abbott Laboratories, a manufacturer of medical devices and tests. Opinion of Kurt Kruger, an analyst at Banc of America Securities, on the viability of the proposed acquisition; Impact of the noncompliance...

  • In Other News.  // Pharmaceutical Representative;May2005, Vol. 35 Issue 5, p14 

    Reports on developments concerning the pharmaceutical industry in the United States, compiled as of May 2005. Public health advisory issued by the Food and Drug Administration (FDA) warning healthcare professionals and patients of a potential cancer risk associated with eczema drugs, Elidel and...

  • IT Headache For Drug Makers. Vinas, Tonya; Jusko, Jill // Industry Week/IW;Jul2002, Vol. 251 Issue 6, p11 

    Reports on the effect of electronic business investments on the pharmaceutical industry in the U.S. Information on an increase in inspections conducted by the U.S. Food and Drug Administration (FDA) on pharmaceutical companies; Requirements of the FDA regarding the computer documents of drug...

  • Pipeline.  // Medical Marketing & Media;Nov2005, Vol. 40 Issue 11, p10 

    Reports on the approval issued by the Food and Drug Administration on drugs produced by pharmaceutical companies in the U.S. Identification of the Humira, an adalimumab for reducing signs and symptoms of active arthritis in patients with psoriatic arthritis from Abbott Laboratories Inc.;...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics